MacDougall Biomedical Communications  
     
     
   

News
Upcoming Events
 
   

8/24/2010 Roche and Aileron Enter Multi-target Alliance to Develop Stapled Peptide Drugs for Diseases across Multiple Therapeutic Areas

8/20/2010 Anchor Therapeutics Secures $10 Million Series B Financing to Advance Pepducin Drug Candidates

7/29/2010 Helicos Announces Nature Publication on First Evidence of RNA Copying Mechanisms in Human Cells

7/29/2010 Rheonix CARD™ Technology Demonstrates Utility in Multiple Molecular Diagnostic Applications at AACC Annual Meeting

7/21/2010 Anchor Therapeutics Adds Global Experts to Board of Directors and Scientific Advisory Board

7/9/2010 Adimab Announces Fifth Major Pharmaceutical Partnership in First Year After Launch of Novel Antibody Discovery Platform

6/29/2010 Claros Diagnostics Receives CE Mark Approval for Point-of-care PSA System

6/25/2010 Helicos BioSciences Announces Launch of Diagnostics Business

6/23/2010 Mersana Initiates Phase 1 Clinical Trial for XMT-1107 in Oncology

5/25/2010 Harvard Clinical Research Institute Expands DAPT Study Into Europe

5/17/2010 ROXRO Announces FDA Approval of SPRIX™

4/29/2010 Artisan Pharma, Inc. Completes Enrollment in 750-patient Phase 2b Study of ART-123 in Sepsis Patients with DIC

3/25/2010 Proteostasis Therapeutics Announces Additions of Key Executives

3/25/2010 Argos Therapeutics Presents New Phase 2a Data on the Impact of Arcelis HIV Program on Viral Genetic Diversity

1/5/2010 Circulite® closes on Series C Financing

12/18/2009 Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals

8/12/2009 Mergers and Acquisitions - The New IPO

8/5/2009 Anesiva, Inc. and Arcion Therapeutics Announce Merger Agreement

8/4/2009 Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective HDAC Inhibitors for Cancer and Rheumatoid Arthritis

7/15/2009 Targacept’s TC-5214 Achieves All Primary and Secondary Outcome Measures in Phase 2b Trial as Augmentation Treatment for Major Depressive Disorder

7/7/2009 Excel Venture Management Launches $125 Million Debut Life Sciences Fund

7/1/2009 CombinatoRx and Neuromed Sign Merger Agreement

6/2/2009 Clinical Data, Inc. Announces Positive Results from Second Phase III Trial of Vilazodone for Depression

5/29/2009 Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation

BioPharm America (EBD Group)
Boston, MA
September 15-17, 2010

BIO Investor Forum
San Francisco, CA
October 5-6, 2010

Download 2009 Life Science Industy Conference Calendar
   

Industry Resources

   
         
   
BIO BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small. Visit website >



MBC The Massachusetts Biotechnology Council is an association of more than 600 biotechnology companies, universities, academic institutions and others dedicated to advancing cutting edge research. We are the leading advocate for the Bay State's world premier life science cluster. Visit website >



EBD Group EBD Group is the leading partnering firm for the global life science industry. Since its inception in 1993, EBD Group’s mission has been to facilitate the biotech-pharma partnerships that deliver tomorrow’s healthcare treatments to patients worldwide. Visit website >